News › Clinical Practice, Industry News, News, Patient Care

Poison Centers See Nearly 1,500% Increase in Calls Related to Injected Weight-loss Drugs As People Accidentally Overdose

December 20, 2023
Hospital beds

Poison control centers across the US say they are seeing a steep increase in calls related to semaglutide, an injected medication used for diabetes and weight loss, with some people reporting symptoms related to accidental overdoses.

Some have even needed to be hospitalized for severe nausea, vomiting and stomach pain, but their cases seem to have resolved after they were given intravenous fluids and medications to control nausea.

From January through November, the America’s Poison Centers reports nearly 3,000 calls involving semaglutide, an increase of more than 15-fold since 2019. In 94% of calls, this medication was the only substance reported.

Read more at CNN >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Advisory Committee to Review Seven Peptides for Potential Use in Compounding
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
Advertisement